Navigation Links
Evolution of root nodule symbiosis with nitrogen-fixing bacteria
Date:3/3/2008

the striking evidence that Parniske and his colleagues had been hoping for.

Our results reveal that an expansion of the functions of SYMRK constituted an important step in the evolution of intracellular nodule symbiosis, reports Parniske. Most plants have a short version of SMYRK, which is required for AM symbiosis. A longer variant of SMYRK was found only in plants involved in the symbiotic relationships with nitrogen-fixing bacteria. Importantly, the longer version was found in both legumes (which form symbioses with rhizobia the textbook nitrogen-fixing symbiosis) and in actinorhiza (such as alder) which form symbiotic relationships with frankia bacteria, about which there is little genetic information. The results therefore suggest a common evolutionary origin of intracellular root symbioses with nitrogen-fixing bacteria.

This work is an important step towards understanding the evolution of nitrogen-fixation in plants, and even whether plants that dont form symbioses with nitrogen-fixing bacteria could be engineered to do so, thus increasing their nutritional value.


'/>"/>

Contact: Natalie Bouaravong
press@plos.org
415-568-3445
Public Library of Science
Source:Eurekalert

Page: 1 2

Related biology news :

1. M2SYS Introduces Revolutionary Biometric Artificial Intelligence Technology to Significantly Reduce Fingerprint Software False Reject Rates
2. The evolution of aversion: Why even children are fearful of snakes
3. Lemurs evolutionary history may shed light on our own
4. MIT: No easy answers in evolution of human language
5. Dartmouth researchers find the root of the evolutionary emergence of vertebrates
6. Tomato pathogen genome may offer clues about bacterial evolution at dawn of agriculture
7. Oldest Australian crayfish fossils provide missing evolutionary link
8. Lessons from evolution applied to national security and other threats
9. Alliance for a Green Revolution in Africa commits 180M to revive farmers depleted soils
10. Biophysical Society to host discussions on the teaching of evolution and on the energy crisis
11. Gene Networks in Animal Development and Evolution Feb. 15 and 16

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...aled how environmental irritants such as air pollu... research published today in the American Journal...uthors of the study, from Imperial College London ...action inside the lungs that can trigger coughing ...n the air. They suggest that their findings may ul...
(Date:11/23/2009)...asty business, posing dangers to human health and ...s launching a new project with funding from the U....ets the fat and grease that contribute to millions...ners new tools to further reduce the risk of sewag...y" sewer systems, as opposed to "combined" systems...
(Date:11/22/2009)...exposed prenatally to tobacco smoke and during chi...DHD, according to research done at Cincinnati Chil...mates that up to 35 percent of ADHD cases in child...by eliminating both of these environmental exposur...en , "Tobacco and lead exposure each have their...
Breaking Biology News(10 mins):Research reveals exactly how coughing is triggered by environmental irritants 2Lose the fat: Targeting grease to curtail sewer overflows 2Exposure to lead, tobacco smoke raises risk of ADHD 2Argonne University of Chicago Scientists Develop Targeted Cancer Treatment Using Nanomaterials 54900 1Argonne University of Chicago Scientists Develop Targeted Cancer Treatment Using Nanomaterials 54900 2Argonne University of Chicago Scientists Develop Targeted Cancer Treatment Using Nanomaterials 54900 3The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 54897 1The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 54897 2The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 54897 3The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 54897 4Treatment May Limit Graft Versus Host Disease 54894 1Treatment May Limit Graft Versus Host Disease 54894 2
...The nature vs. nurture debate is familiar to most ...alance between the two. A new paper published this...s that there is a similar balance between the gene... determining thousands of traits in yeast. As we a...h of us knows something about the genetic variatio...
...SAN DIEGO Genetic variations ensure that no two p...searchers now have the tools and the knowledge to ...rapy, enabling more precise and effective treatmen...ciation for Cancer Research, April 12 16, researc...ct response to well known treatments for breast ca...
...PHILADELPHIA Reinforcing its commitment to suppor... Dorothy P. Landon Foundation have again partnered... (AACR) to create two new funding opportunities, t...er Prevention Research and the Landon Foundation-A...n in Cancer Research. These awards, each offering...
Other Biology News:Biomarkers allow doctors to match therapy to patient 2Biomarkers allow doctors to match therapy to patient 3Biomarkers allow doctors to match therapy to patient 4Biomarkers allow doctors to match therapy to patient 5Biomarkers allow doctors to match therapy to patient 6Biomarkers allow doctors to match therapy to patient 7Landon Foundation-AACR INNOVATOR Awards 2Landon Foundation-AACR INNOVATOR Awards 3Landon Foundation-AACR INNOVATOR Awards 4
(Date:11/23/2009)...ABY,BC,Nov.23/PRNewswire/-InimexPharmaceuticals,In...Ph.DasitsPresidentandCEO. ,, Abramsbringsmoreth...Inimex.Heisaco-inventorofthenuclearmedicineimaging...atthey,plcwherehewasManager,BiomedicalResearchWorl...angley,BCandwasPresidentandCEOfrom1996to2006.AnorM...
(Date:11/20/2009)...Latin American countries have an opportunity to ta...searchers from the University of Valencia (UV), wo...tudied the productive fabric of the Spanish biotec... food and plant sectors have more clout than those...as applied to food and plants has been overlooked ...
(Date:11/20/2009)..., SEATTLE, Nov. 20 Cell...nnounced today that the Ninth Circuit Court of App...d that CTI should be allowed to pursue all of its ...ck to the District Court for trial. CTI filed a c...d-party reimbursement consultant for CTI,s product...
(Date:11/19/2009)...EATTLE, Nov. 19 Omeros C...ted financial results for the third quarter ended ...tember 30, 2009, Omeros reported a net loss of $3....t loss of $7.4 million, or $2.54 per share, for th...eptember 30, 2009, the Company reported a net loss...
Breaking Biology Technology:Inimex Announces Appointment of New CEO 2Spanish biotechnology should focus on food and plant sectors to be more competitive 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8
...d Notes Achievements over 4-year Period, Progress... Preparing for Challenges of 2008, K...ion (NYSE: SGP ) today reported financial results...mmented on its ongoing integration of,Organon BioS... 2007 and,includes the Organon human health busine...
...ference at the Waldorf-Astoria in New York ... YORK, Feb. 12 BIO CEO & Investor,conference -- J...erapeutics, Inc. (CTI) (Nasdaq: CTIC ; MTAX) will...rketing strategy intended to grow Zevalin(R),(Ibri...s figure reported,for 2007. CTI completed the acqu...
...(Nasdaq: MAXY ), a biotechnology company focused ...y announced that it will present at the Roth,20th ...uary 19, 2008 at,9:00 a.m. Pacific Time. Russell H...ent. A live webcast of the presentation can be acc...com/webcasts . A replay of the,presentation will b...
Other Biology Technology:Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 2Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 3Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 4Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 5Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 6Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 7Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 8Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 9Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 10Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 11Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 12Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 13Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 14Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 15Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 16Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 17Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 18Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 19Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 20Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 21Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 22Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 23Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 24Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 25Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 26Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 27Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year 28Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008 2Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008 3Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008 4Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008 5
Goat Anti-Human Xg Affinity Purified Polyclonal Antibody, Unconjugated from R&D Systems
Japanese medaka Vitellogenin Standard from Cayman Chemical
Mouse Collagen IV, Unconjugated from R&D Systems
Captivate disposable sample chamber - for Captivate magnetic yoke - set of 10 from Molecular Probes (Invitrogen)
Biology Products: